From: Sleep in post-COVID-19 recovery period and its impact on different domains of quality of life
The studied group (n = 500) | |
---|---|
Score of insomnia severity index | 13.01 ± 4.9 |
0–7 = No clinically significant insomnia | 44 (8.8%) |
8–14 = subthreshold insomnia | 296 (59.2%) |
15–21 = clinical insomnia (moderate severity) | 133 (26.6%) |
22–28 = clinical insomnia (severe) | 27 (5.4%) |
Global PSQI Score | 15.37 ± 4.43 |
Global PSQI Score components | |
Subjective sleep quality | 2.10 ± 0.94 |
Sleep latency | 2.35 ± 0.74 |
Sleep duration | 2.16 ± 0.85 |
Sleep efficiency | 2.15 ± 0.86 |
Sleep disturbance | 2.18 ± 0.85 |
Use of sleep medication | 2.23 ± 0.83 |
Daytime dysfunction | 2.21 ± 0.79 |